Sponsored • Solutions aligned with global clinical market needs
Innovative biomedical solutions from Taipei presented at MEDICA 2025
The global healthcare sector faces key challenges—aging populations, staff shortages, and quality demands. With Taipei City Government's support, six Taipei companies will showcase innovative biotech and medical device solutions at MEDICA 2025 (November 17–20, Düsseldorf), advancing healthcare with speed and precision.
Image source: Neurobit Technologies
The Digital Diagnostic Revolution: From "Invisible to the Naked Eye" to "AI-Powered Neural Detection"
In neurological care, early minor lesions are often missed, causing delayed diagnoses. Neurobit's NeuroSwift Pro system addresses this "diagnostic black hole" by transforming subtle physiological signals—such as eye movements, pupil responses, and vestibular data—into digital markers for high-risk brain disorders. The AI-assisted system accurately detects early signs of abnormal nystagmus in Parkinson's disease, central vertigo, and post-concussion syndrome. It replaces the subjective judgment of clinicians with objective data from the AIVertigo platform, thereby improving diagnostic accuracy and streamlining outpatient workflows. This innovation has received FDA approval in the United States and sets a new standard for efficient digital healthcare in brain health.
>> Visit Neurobit Technologies at MEDICA 2025: Hall 16, C13-7
Company website: https://www.neurobittech.com/
Image source: Origin Biotechnology
Precision Prevention Leads the Way: The Speed and Scale Revolution of Genetic Testing
Origin is advancing genetic disease prevention by prioritizing speed and comprehensiveness in high-risk diagnostics and newborn screening. The company offers a single integrated PCR–CE panel covering SMA, DMD, Fragile X, and Thalassemia (α/β) that reports in 3 hours. The high-multiplex, single-tube assay quantifies SMN1/SMN2 copy number, detects DMD exon CNVs including ins/del, profiles FMR1 CGG expansions, and consolidates α/β-thal targets, delivering a high-precision, low-complexity workflow on standard CE instruments. Designed to replace routine methods, it delivers broader coverage, shorter hands-on/turnaround times, and a simpler workflow.
Beyond this panel, Origin's PCR–CE portfolio supports a complete maternal–child pathway—carrier, prenatal, and newborn screening—and related men's health testing.
>> Visit Origin Biotechnology at MEDICA 2025: Hall 16, C13-3
Company website: https://www.oribio.com.tw/en/home
Image source: GuiderCare
Smart Hospital Rooms: Large-Scale IoT-Powered Monitoring and AI-Driven Personalized Care
In today's increasingly complex hospital environments, efficient and continuous monitoring of large patient populations is key to improving nursing efficiency and patient safety. GuiderCare's solution centers on a large-scale, high-efficiency IoT platform. Its core 300B medical wearable system seamlessly connects patient wearables with Bluetooth gateways and hospital management backends for real-time data monitoring. For nursing staff and administrators, it delivers AI-powered personalized care support, thereby enhancing patient safety and streamlining care workflows. Additionally, devices such as the 900Q\ 4G medical smartwatch extend real-time communication, location tracking, and health monitoring.
>> Visit GuiderCare at MEDICA 2025: Hall 16, C13-5
Company website: https://www.guidercare.com/en
The Ultimate Challenge in Minimally Invasive Surgery: Innovative Anti-Adhesion Solutions
Image source: Proview-MBD
Postoperative tissue adhesion is a common complication, often causing chronic pain and costly reoperations, especially in minimally invasive procedures.
Proview-MBD addresses this challenge with ThergiSpray, a temperature-sensitive, single-dose liquid spray for easy application in minimally invasive surgeries. It forms a stable barrier on complex internal wounds, offering simplicity, efficiency, and cost-effectiveness for healthcare facilities.
The technology is patented in the EU, US, China, Japan, and Taiwan, demonstrating global recognition.
For spinal surgeries, AtamaBarrier provides a temporary epidural barrier, reducing adhesion, lowering the risk of chronic pain and nerve damage, and improving patient outcomes.
>> Visit Proview-MBD at MEDICA 2025: Hall 16, C13-8
Company website: http://www.mbdbiotech.org/
Breaking the High-Risk Barrier: Advances in Hospital Infection Control and Emergency Care
Image source: Union Biomedical
Union Biomedical International delivers targeted solutions for high-risk hospital environments. Its flagship innovation is a fully automatic low-temperature endoscope sterilization system that integrates a complex four-step process—cleaning, disinfection, sterilization, and drying—into a single operation, completing it in just 30 minutes while processing two endoscopes simultaneously. This significantly reduces the risk of equipment-related infections in healthcare settings. In addition, Union Liquid Bandage offers a safe, non-irritating alternative to traditional disinfectants and accelerates wound and burn healing. This innovation holds strong potential for use in battlefield trauma care and everyday emergency treatment.
>> Visit Union Biomedical International, USA at MEDICA 2025: Hall 16, C13-4
The Next Era of Medical Textiles: Comfort Meets Compliance
Image source: Asiatic Fiber Corporation
As hospitals move toward sustainable and high-performance apparel, AFC introduces the Air Scrub Suit-C-R15—a breakthrough fabric designed to redefine medical apparel by combining EN13795-2 High Performance protection, extreme breathability, and outstanding moisture management (RET 2.54). Even during long, high-intensity shifts, it quickly wicks away sweat to keep healthcare professionals dry and comfortable, while maintaining a soft, activewear-like feel.
Engineered with conductive yarn for superior static control, Air Scrub Suit-C-R15 withstands high-temperature sterilization and repeated washing, and its ultra-fast drying reduces dryer time and energy use, supporting hospitals' sustainability goals.
>> Visit Asiatic Fiber Corporation at MEDICA 2025: Hall 16, C13-6
Company website: https://asiatic.com.tw/en/
At MEDICA 2025 in Germany, Taipei's biomedical industry will demonstrate global ambition and innovation, underscoring the city's drive to be a leading biotech hub.
Follow Bio@Taipei for updates.
Source: China Productivity Center
28.10.2025
